Why the study?
Infective endocarditis carries high mortality despite medical therapy, and less invasive interventions are needed for source control in nonsurgical candidates.
Does vacuum-assisted thrombectomy provide effective source control in a critically ill patient with right atrial infective endocarditis who is a poor surgical candidate?
Does vacuum-assisted thrombectomy provide effective source control in a critically ill patient with right atrial infective endocarditis who is a poor surgical candidate?
Vacuum-assisted thrombectomy may offer a less invasive, life-saving option for source control in critically ill patients with right-sided infective endocarditis who are poor surgical candidates.
May offer source control option in nonsurgical infective endocarditis; leaves open safety and efficacy for prospective validation.
Infective endocarditis has a high mortality rate despite appropriate medical therapy. In patients who are not surgical candidates, source control can be achieved with less invasive intervention. This case report describes a 47-year-old male with a complex medical history who presented in septic shock with recurrent bacteremia. Transesophageal echocardiogram showed the right atrial septal vegetation, but multiple medical comorbidities rendered the patient a poor surgical candidate. He underwent successful vacuum-assisted thrombectomy with the FlowTriever System ™ (Inari Medical, Inc.) and was discharged home 6 days after the procedure. Intervention with this device can provide life-saving therapy in critically ill patients.
No takes yet. Share an insight, caveat, or question.
Mayo et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: